New study challenges role of rectal exam in prostate cancer screening

A study by the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital has taken a closer look at the effectiveness of common examination methods for the early detection of prostate cancer.

CPSI Rebrands as TruBridge

What You Should Know: – CPSI (NASDAQ: CPSI) announced a strategic rebranding, transitioning to TruBridge, Inc. (“TruBridge”) effective March 4, 2024. – The rebrand reflects

February 23, 2024

Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections

Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than intramuscular bivalent mRNA boosters.

September 5, 2024

Robitussin Recalled; Rare Infection in Vermont; Don’t Eat Fried Toothpicks

Note that some links may require registration or subscription. Haleon issued a voluntary recall of eight lots of Robitussin Honey CF Max Day Adult and

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.